Haploinsufficiency of HDAC4 causes brachydactyly mental retardation syndrome, with brachydactyly type E, developmental delays, and behavioral problems.

[1]  S. Mundlos,et al.  Deletion and point mutations of PTHLH cause brachydactyly type E. , 2010, American journal of human genetics.

[2]  Deborah L. Levy,et al.  A recurrent 16p12.1 microdeletion suggests a two-hit model for severe developmental delay , 2010, Nature Genetics.

[3]  M. Chiong,et al.  The transcription factor MEF2C mediates cardiomyocyte hypertrophy induced by IGF-1 signaling. , 2009, Biochemical and biophysical research communications.

[4]  Stephen R. Williams,et al.  Array comparative genomic hybridisation of 52 subjects with a Smith–Magenis-like phenotype: identification of dosage sensitive loci also associated with schizophrenia, autism, and developmental delay , 2009, Journal of Medical Genetics.

[5]  Axel Benner,et al.  FARP2, HDLBP and PASK are downregulated in a patient with autism and 2q37.3 deletion syndrome , 2009, American journal of medical genetics. Part A.

[6]  Santhosh Girirajan,et al.  A functional network module for Smith–Magenis syndrome , 2009, Clinical genetics.

[7]  Constance L. Cepko,et al.  HDAC4 Regulates Neuronal Survival in Normal and Diseased Retinas , 2009, Science.

[8]  K. Casas,et al.  Chromosome 2q37 deletion: Clinical and molecular aspects , 2007, American journal of medical genetics. Part C, Seminars in medical genetics.

[9]  Kenny Q. Ye,et al.  Strong Association of De Novo Copy Number Mutations with Autism , 2007, Science.

[10]  John McAnally,et al.  MEF2C transcription factor controls chondrocyte hypertrophy and bone development. , 2007, Developmental cell.

[11]  G. Karsenty,et al.  PTH/PTHrP receptor delays chondrocyte hypertrophy via both Runx2-dependent and -independent pathways. , 2006, Developmental biology.

[12]  M. Humbert,et al.  BMPR2 gene rearrangements account for a significant proportion of mutations in familial and idiopathic pulmonary arterial hypertension , 2006, Human mutation.

[13]  J. Piven,et al.  Evaluation of the chromosome 2q37.3 gene CENTG2 as an autism susceptibility gene , 2005, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[14]  K. Devriendt,et al.  RAI1 variations in Smith–Magenis syndrome patients without 17p11.2 deletions , 2005, Journal of Medical Genetics.

[15]  K. Reddy Cytogenetic abnormalities and fragile-x syndrome in Autism Spectrum Disorder , 2005, BMC Medical Genetics.

[16]  A E Shrimpton,et al.  Molecular delineation of deletions on 2q37.3 in three cases with an Albright hereditary osteodystrophy‐like phenotype , 2004, Clinical genetics.

[17]  John M. Shelton,et al.  Histone Deacetylase 4 Controls Chondrocyte Hypertrophy during Skeletogenesis , 2004, Cell.

[18]  R. Hennekam,et al.  Molecular analysis of 20 patients with 2q37.3 monosomy: definition of minimum deletion intervals for key phenotypes , 2004, Journal of Medical Genetics.

[19]  Chun Li Zhang,et al.  Class II Histone Deacetylases Act as Signal-Responsive Repressors of Cardiac Hypertrophy , 2002, Cell.

[20]  M. Spence,et al.  Molecular genetic delineation of 2q37.3 deletion in autism and osteodystrophy: report of a case and of new markers for deletion screening by PCR , 2001, Cytogenetic and Genome Research.

[21]  N. Kanatani,et al.  Skeletal Malformations Caused by Overexpression of Cbfa1 or Its Dominant Negative Form in Chondrocytes , 2001, The Journal of cell biology.

[22]  S. Takeda,et al.  Continuous expression of Cbfa1 in nonhypertrophic chondrocytes uncovers its ability to induce hypertrophic chondrocyte differentiation and partially rescues Cbfa1-deficient mice. , 2001, Genes & development.

[23]  S. Schreiber,et al.  Three proteins define a class of human histone deacetylases related to yeast Hda1p. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[24]  W. Dobyns,et al.  Albright hereditary osteodystrophy and del(2) (q37.3) in four unrelated individuals. , 1995, American journal of medical genetics.

[25]  J. Flint,et al.  Brachydactyly and mental retardation: an Albright hereditary osteodystrophy-like syndrome localized to 2q37. , 1995, American journal of human genetics.

[26]  F. Dequiedt,et al.  Enzymatic activity associated with class II HDACs is dependent on a multiprotein complex containing HDAC3 and SMRT/N-CoR. , 2002, Molecular cell.

[27]  E. Olson,et al.  MEF2: a calcium-dependent regulator of cell division, differentiation and death. , 2002, Trends in biochemical sciences.

[28]  J. Charles,et al.  Pilot assessment of the subtelomeric regions of children with autism: Detection of a 2q deletion , 2002, Genetics in Medicine.

[29]  B. Black,et al.  Transcriptional control of muscle development by myocyte enhancer factor-2 (MEF2) proteins. , 1998, Annual review of cell and developmental biology.